argenx SE

ARGX | NASDAQ

Price Alert Chart Builder DCF Calculator

$998.13

+$7.81 (+0.79%)

Sep 21, 2026, 12:10 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Pro Subscription

Upgrade now for unlimited access to all data, tools and no ads.

Upgrade now ➞

Related Stocks

Company	Yield
A Agilent	0.65%
ALC Alcon	0.55%
ALNY Alnylam Pharmaceuticals	N/A
BDX Becton, Dickinson and Company	2.20%
CAH Cardinal Health	0.91%
EW Edwards Lifesciences	N/A
HLN Haleon plc	2.16%
IDXX IDEXX Laboratories	N/A
REGN Regeneron Pharmaceuticals	0.47%
VEEV Veeva Systems	N/A

Dividend Rankings ➞

Recent News

1 day ago / fool.com
2 Wall Street Analysts Think Argenx Can Soar More Than 40%. Here's Why They're Right.
3 days ago / zacks.com
BMY vs. ARGX: Which Stock Is the Better Value Option?
4 days ago / globenewswire.com
argenx announces results of Extraordinary General Meeting of Shareholders and appointment of Thomas M. Brakel and Khurem Farooq as Non-Executive Directors
4 days ago / defenseworld.net
Tidal Investments LLC Grows Holdings in argenex SE $ARGX
7 days ago / seekingalpha.com
argenx SE (ARGX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
19 days ago / fool.com
Argenx Has Delivered 18 Consecutive Quarters of Sales Growth -- but Is the Biotech Stock Still Underrated?
21 days ago / globenewswire.com
argenx to Present at Upcoming Investor Conferences
26 days ago / fool.com
Argenx Just Landed Another Phase 3 Win -- and Wall Street May Be Missing the Bigger Story
1 month ago / defenseworld.net
argenx VYVGART Hits Phase III Goal in Autoimmune Myositis, Eyes IMNM Filing
1 month ago / zacks.com
ARGX Announces Positive Phase III Data on Vyvgart Hytrulo, Stock Up